|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma 显示文摘 | Piekarz RL Frye R Prince HM | 2011 | Blood2011，117，22： | 1 |
| 2 | Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors 显示文摘 | Grant C Rahman F Piekarz R | 2010 | Expert Rev Anticancer Ther2010，10，7： | 1 |
| 3 | Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma显示文摘 | PIEKARZ RL FRYE R TURNER M | 2009 | J Clin Oncol2009，27，32： | 1 |
| 4 | Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma显示文摘 | Piekarz RL Frye AR Wright J J | 2006 | Clin Cancer Res2006，12，12： | 1 |
| 5 | Influence of Asian and Western United States urban areas and fires on the atmospheric transport of polycyclic aromatic hydrocarbons, polychlorinated biphenyls, and fluorotelomer alcohols in the Western United States 显示文摘 | Primbs T Piekarz A Wilson G | 2008 | Environmental Science and Technology2008，42，17： | 1 |
| 6 | Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors 显示文摘 | GRANT C RAHMAN F PIEKARZ R | 2010 | Expert Rev Anticancer Ther2010，10，7： | 1 |
| 7 | Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma显示文摘 | PIEKARZ RL FRYE AR WRIGHT JJ | 2006 | Clin Cancer Res2006，12，12： | 1 |
| 8 | Histone deacetylase inhibitors and demethylating agents: clinical development ofhistone deacetylase in- hibitors for cancer therapy显示文摘 | Piekarz RL Sackett DL Bates SE | 2007 | Cancer J2007，13，： | 1 |
| 9 | Phase 11 trial of Romidepsin in patients with peripheral T-cell lymphoma显示文摘 | Piekarz RL Frye R Prince HM | 2011 | Blood2011，117，22： | 1 |
| 10 | Inhibitor of histone deacetylation,depsipeptide(FR901228),in the treatment of peripheral and cutaneous T-cell lymphoma:a case report显示文摘 | Piekarz RL Robey R Sandor V | 2001 | Blood2001，98，9： | 1 |
| 11 | Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma显示文摘 | Piekarz RL Frye R Prince HM | 2011 | Blood2011，117，22： | 1 |
| 12 | Phonon - induced hole - hole effective interactions in the cuprates显示文摘 | Piekarz P Konior J | 2001 | Physical Review B2001，63，21： | 1 |
| 13 | Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma显示文摘 | Piekarz RL Frye R Turner M | | 0，，32： | 1 |
| 14 | Inhibitor of histone deacetylation,depsipeptide (FR901228),in the treatment of peripheral and cutaneous T-cell lymphoma:a case report显示文摘 | Piekarz RL Robey R Sandor V Bakke S Wilson WH Dahmoush L | 2001 | Blood2001，98，9： | 1 |
| 15 | Epigenetic modifiers:basic understanding and clinical development显示文摘 | Piekarz RL Bates SE | 2009 | Clin Cancer Res2009，15，12： | 1 |
| 16 | A review of depsipeptide and other histone deacetylase inhibitors in clinical trials显示文摘 | Piekarz R Bates S | 2004 | Curr Pharm Des2004，10，19： | 1 |
| 17 | T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy:impact of depsipeptide on molecular markers,therapeutic targets and mechanisms of resistance显示文摘 | Piekarz RL Robey RW Zhan Z | 2004 | Blood2004，103，12： | 1 |
| 18 | Phase Ⅱ multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma显示文摘 | Piekarz RL Frye R Turner M | 2009 | J Clin Oncol2009，27，： | 1 |
| 19 | Inhibitor of histone deacetylatio depsipeptide (FR901228) in the treatment of peripheral and cutaneous T cell lymphoma:a case report显示文摘 | Piekarz RL Robey R Sandor V | 2001 | Blood2001，98，9： | 1 |
| 20 | Phase II multi-institution- al trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-eeU lymphoma 显示文摘 | Piekarz RL Frye R Turner M | 2009 | J Clin Oneol2009，27，32： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员